MCID: PRP009
MIFTS: 42

Peripartum Cardiomyopathy malady

Categories: Rare diseases, Reproductive diseases, Cardiovascular diseases

Aliases & Classifications for Peripartum Cardiomyopathy

About this section
Sources:
31ICD10 via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Peripartum Cardiomyopathy:

Name: Peripartum Cardiomyopathy 48 54 68
Postpartum Cardiomyopathy 48 54 68
 
Meadows' Syndrome 48

Characteristics:

Orphanet epidemiological data:

54
postpartum cardiomyopathy:
Age of onset: Adult

Classifications:



External Ids:

Orphanet54 ORPHA563
UMLS via Orphanet69 C0877208, C0269972
ICD10 via Orphanet31 O90.3

Summaries for Peripartum Cardiomyopathy

About this section
Wikipedia:71 Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that is defined as a deterioration... more...

MalaCards based summary: Peripartum Cardiomyopathy, also known as postpartum cardiomyopathy, is related to transmitted_by and cardiomyopathy. An important gene associated with Peripartum Cardiomyopathy is PRL (Prolactin), and among its related pathways are Melatonin metabolism and effects and cAMP signaling pathway. Affiliated tissues include heart, myeloid and cardiac myocytes, and related mouse phenotypes are cardiovascular system and muscle.

Related Diseases for Peripartum Cardiomyopathy

About this section

Diseases related to Peripartum Cardiomyopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 78)
idRelated DiseaseScoreTop Affiliating Genes
1transmitted_by32.0DRD2, PRL
2cardiomyopathy11.0
3rhinoscleroma10.2DRD2, PRL
4lung occult small cell carcinoma10.2DRD2, PRL
5ornithosis10.2DRD2, PRL
6pulmonary neuroendocrine tumor10.2DRD2, PRL
7luxation of globe10.2ADRB1, PRL
8aplasia cutis congenita recessive10.2ADRB1, GNB3
9infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.1DRD2, PRL
10dilated cardiomyopathy10.1
11nephrogenic adenoma of the urethra10.1DRD2, PRL
12cold-induced sweating syndrome 210.1DRD2, PRL
13left ventricular noncompaction10.0
14pre-eclampsia10.0
15eclampsia10.0
16celiac disease 210.0MYH7, TTN
17lyme disease10.0MYH7, TTN
18familial sick sinus syndrome10.0GNB3, SCN5A
19cardiac arrest10.0
20bile acid synthesis defect, congenital, 410.0DRD2, PRL
21muscular dystrophy, rigid spine, 110.0MYH7, TTN
22trs2-related diamond-blackfan anemia with mandibulofacial dysostosis9.9MYH7, SCN5A
23ndp-related retinopathy of prematurity9.9MYH7, SCN5A
24selenon-related myopathy9.9MYH7, SCN5A
25sema4a-related retinitis pigmentosa9.9MYH7, SCN5A
26sudden infant death syndrome9.9MYH7, SCN5A
27ostertagiasis9.9MYH7, TTN
28hyperprolactinemia9.9
29pulmonary edema9.9
30myocarditis9.9
31mosaic trisomy 19.9MYH7, SCN5A
32retinitis pigmentosa 189.9MYH7, SCN5A
33tardbp-related frontotemporal dementia9.9MYH7, SCN5A
34myocardial infarction9.8
35systemic lupus erythematosus9.8
36ventricular septal defect9.8
37lupus erythematosus9.8
38pulmonary embolism9.8
39cardiogenic shock9.8
40primary cutaneous gamma/delta-positive t-cell lymphoma9.7MYH7, SCN5A, TTN
41pollen allergy9.7MYH7, SCN5A, TTN
42schizophrenia9.7
43obesity9.7
44wolff-parkinson-white syndrome9.7
45duchenne muscular dystrophy9.7
46acute myocardial infarction9.7
47congestive heart failure9.7
48hepatitis9.7
49leukemia9.7
50myasthenia gravis9.7

Graphical network of the top 20 diseases related to Peripartum Cardiomyopathy:



Diseases related to peripartum cardiomyopathy

Symptoms & Phenotypes for Peripartum Cardiomyopathy

About this section

MGI Mouse Phenotypes related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.1ADRB1, CHRM2, DRD2, MYH7, SCN5A, TTN
2MP:00053697.4ADRB1, CHRM2, DRD2, MYH7, SCN5A, TTN

Drugs & Therapeutics for Peripartum Cardiomyopathy

About this section

Drugs for Peripartum Cardiomyopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Seleniumapproved, vet_approvedPhase 41807782-49-2
Synonyms:
Selanediide
Selen
Selenide
Selenide(2-)
Selenio
 
Selenium
Selenium elemental
Selenium ion (Se2+)
Selenium metallicum
Selenium, elemental
Sélénium
2MicronutrientsPhase 46001
3Trace ElementsPhase 46001
4AntioxidantsPhase 43050
5Sodium SelenitePhase 418
6Selenious AcidPhase 415
7Protective AgentsPhase 47443
8
Bromocriptineapproved, investigationalPhase 3, Phase 23125614-03-331101
Synonyms:
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
2-bromo-α-ergocryptine
2-bromo-α-ergokryptin
2-bromo-α-ergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
AC-13601
AC1L1KXS
AC1Q2716
Alti-Bromocriptine
Apo-Bromocriptine
BIDD:GT0464
BPBio1_001131
BRD-K14496212-001-01-1
Bagren
Biomol-NT_000005
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
Bromocriptine (USAN/INN)
Bromocriptine Methanesulfonate
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
 
Bromocriptine methanesulfonate
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CB-154
CCRIS 3244
CHEBI:3181
CHEMBL493
CID31101
D03165
DB01200
EINECS 247-128-5
Ergocryptine, 2-bromo- (8CI)
Ergoset
LS-64540
Lopac0_000171
MolPort-002-512-064
NCGC00024584-04
NCI60_001365
NSC169774
PDSP2_001500
Parlodel
Parlodel Snaptabs
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SPBio_002101
UNII-3A64E3G5ZO
bromocriptine
nchembio873-comp18
9
DopamineapprovedPhase 3, Phase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
10
Heparinapproved, investigationalPhase 38489005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
11
DalteparinapprovedPhase 33179041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Heparin Fragment KABI 2165
Tedelparin
12Hormone AntagonistsPhase 3, Phase 213180
13HormonesPhase 3, Phase 214415
14Neurotransmitter AgentsPhase 3, Phase 218340
15Antiparkinson AgentsPhase 3, Phase 21574
16Dopamine AgentsPhase 3, Phase 23836
17Dopamine agonistsPhase 3, Phase 2632
18Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 213168
19Heparin, Low-Molecular-WeightPhase 3334
20calcium heparinPhase 3848
21Angiotensin-Converting Enzyme InhibitorsPhase 2724

Interventional clinical trials:

idNameStatusNCT IDPhase
1Peripartum Cardiomyopathy in Nigeria RegistryNot yet recruitingNCT03081949Phase 4
2Bromocriptine in the Treatment of Peripartum CardiomyopathyNot yet recruitingNCT02590601Phase 3
3Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum CardiomyopathyCompletedNCT00998556Phase 2
4Registry and Survey of Women With Pregnancy Related CardiomyopathyUnknown statusNCT00273637
5Investigation in Pregnancy Associate CardiomyopathyCompletedNCT01085955
6The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE StudyRecruitingNCT02357667

Search NIH Clinical Center for Peripartum Cardiomyopathy

Genetic Tests for Peripartum Cardiomyopathy

About this section

Anatomical Context for Peripartum Cardiomyopathy

About this section

MalaCards organs/tissues related to Peripartum Cardiomyopathy:

36
Heart, Myeloid, Cardiac myocytes, Testes, Lung, Liver, Brain

Publications for Peripartum Cardiomyopathy

About this section

Articles related to Peripartum Cardiomyopathy:

(show top 50)    (show all 550)
idTitleAuthorsYear
1
Re: Myocardial Recovery in Peripartum Cardiomyopathy after Hyperprolactinemia Treatment on Biventricular Assist Device. (28114195)
2017
2
Peripartum Cardiomyopathy in Cardiac MRI: A Case Report. (27846644)
2017
3
Peripartum cardiomyopathy, place of drug therapy, assist devices, and outcome after left ventricular assistance. (27776335)
2017
4
Re: Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on Biventricular Assist Device. (28169846)
2017
5
Myocardial Recovery in Peripartum Cardiomyopathy After Hyperprolactinemia Treatment on BIVAD. (27748657)
2017
6
Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: A 15-year nationwide population-based study in Asia. (28489799)
2017
7
Low STAT3 expression sensitizes to toxic effects of I^-adrenergic receptor stimulation in peripartum cardiomyopathy. (27002120)
2016
8
Characteristics and In-Hospital Outcomes of Peripartum Cardiomyopathy Diagnosed During Delivery in the United States From the Nationwide Inpatient Sample (NIS) Database. (26923643)
2016
9
Peripartum cardiomyopathy: a systematic literature review. (27545093)
2016
10
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. (27338866)
2016
11
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome. (27399926)
2016
12
Peripartum cardiomyopathy with subclinical hypothyroidism - A rare case presentation. (27728018)
2016
13
The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy? (27126284)
2016
14
An airport meeting that led to bromocriptine use in peripartum cardiomyopathy. (28007932)
2016
15
Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes. (27166247)
2016
16
Clinical Profi le and Predictors of Outcomes of Patients with Peripartum Cardiomyopathy: The Philippine Heart Center Experience. (27942536)
2016
17
Clinical Characteristics and Prognosis of Peripartum Cardiomyopathy in 28 Patients. (26956861)
2016
18
Coincidence of peripartum cardiomyopathy and systemic lupus erythematosus. (27150565)
2016
19
Women's Experiences Being Diagnosed With Peripartum Cardiomyopathy: A Qualitative Study. (27285199)
2016
20
Peripartum cardiomyopathy: challenges in diagnosis and management. (27276444)
2016
21
BMI Is a Potential Confounder of Postpartum Relaxin-2 and Short-Term Left Ventricular Function Following Peripartum Cardiomyopathy. (27364970)
2016
22
Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres. (26789488)
2016
23
Cabergoline in the Treatment of Peripartum Cardiomyopathy. (27583690)
2016
24
Peripartum cardiomyopathy in a patient treated for acute myeloid leukemia. (27276863)
2016
25
Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients. (28029641)
2016
26
Physiological Reduction in Left Ventricular Contractile Function in Healthy Postpartum Women: Potential Overlap with Peripartum Cardiomyopathy. (26859567)
2016
27
Immunosuppression therapy in the management of peripartum cardiomyopathy: A case series and literature review. (27829880)
2016
28
Right ventricular systolic dysfunction and remodelling in Nigerians with peripartum cardiomyopathy: a longitudinal study. (26821537)
2016
29
Cardiac arrest during emergency cesarean section for severe pre-eclampsia and peripartum cardiomyopathy. (26927264)
2016
30
A rare case of peripartum cardiomyopathy with atrial septal defect. (27728087)
2016
31
Veno-venous ECMO as a safe bridge to recovery in a patient with severe peripartum cardiomyopathy - learning from errors. (27881700)
2016
32
Peripartum cardiomyopathy: a case of patient with triplet pregnancy. (27132428)
2016
33
Safe and Effective Use of Pharmacologic and Device Therapy for Peripartum Cardiomyopathy. (27373996)
2016
34
Impellaa8c Left Ventricular Assist Device for Acute Peripartum Cardiomyopathy After Cesarean Delivery. (27224038)
2016
35
When it rains, it pours: Peripartum cardiomyopathy with features of left-ventricular noncompaction in a hemodialysis patient. (27147549)
2016
36
Peripartum Cardiomyopathy From a Genetic Perspective. (27385280)
2016
37
Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update. (26925403)
2016
38
Decreased expression of programmed death 1 on peripheral blood lymphocytes disrupts immune homeostasis in peripartum cardiomyopathy. (27580218)
2016
39
Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy. (27342869)
2016
40
Peripartum cardiomyopathy: Frequency and predictors and indicators of clinical outcome. (27924958)
2016
41
Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. (26970832)
2016
42
Early ivabradine treatment in patients with acute peripartum cardiomyopathy: Subanalysis of the German PPCM registry. (27156059)
2016
43
GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study. (26915373)
2016
44
Expression of programmed cell death-1 and its ligand B7 homolog 1 in peripheral blood lymphocytes from patients with peripartum cardiomyopathy. (28026044)
2016
45
Response: "Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: An Update". (27200354)
2016
46
Mechanical circulatory support for patients with peripartum cardiomyopathy. (27003430)
2016
47
Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome. (27875851)
2016
48
One Year Survival in Nigerians with Peripartum Cardiomyopathy. (27512533)
2016
49
Use of Prolactin Inhibition in the Treatment of Peripartum Cardiomyopathy. (27658008)
2016
50
Quality of Life in Survivors of Peripartum Cardiomyopathy. (27239023)
2016

Variations for Peripartum Cardiomyopathy

About this section

Expression for genes affiliated with Peripartum Cardiomyopathy

About this section
Search GEO for disease gene expression data for Peripartum Cardiomyopathy.

Pathways for genes affiliated with Peripartum Cardiomyopathy

About this section

GO Terms for genes affiliated with Peripartum Cardiomyopathy

About this section

Cellular components related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1axon terminusGO:004367910.4CHRM2, DRD2
2muscle myosin complexGO:00058599.9MYH7, TTN
3dendriteGO:00304259.8CHRM2, DRD2, GNB3
4lateral plasma membraneGO:00163289.8DRD2, SCN5A
5Z discGO:00300188.5MYH7, SCN5A, TTN

Biological processes related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1adenylate cyclase-activating adrenergic receptor signaling pathwayGO:007188010.3ADRB1, DRD2
2adenylate cyclase-modulating G-protein coupled receptor signaling pathwayGO:000718810.3CHRM2, DRD2
3muscle filament slidingGO:00300499.9MYH7, TTN
4positive regulation of epithelial cell proliferationGO:00506799.8PRL, SCN5A
5temperature homeostasisGO:00016599.7ADRB1, DRD2
6striated muscle contractionGO:00069419.7MYH7, TTN
7cardiac muscle contractionGO:00600489.1MYH7, SCN5A, TTN
8regulation of heart rateGO:00020279.1DRD2, MYH7, SCN5A

Molecular functions related to Peripartum Cardiomyopathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1adrenergic receptor activityGO:000493510.3ADRB1, DRD2
2calmodulin bindingGO:00055168.5MYH7, SCN5A, TTN

Sources for Peripartum Cardiomyopathy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet